暫無數據
代碼股票名稱
最新價漲跌額漲跌幅成交量成交額今開昨收最高最低總市值流通市值總股本流通股本5日漲跌幅10日漲跌幅20日漲跌幅60日漲跌幅120日漲跌幅250日漲跌幅年初至今漲跌幅股息率TTM換手率市盈率TTM市盈率(靜)振幅所屬行業
美股期權個股詳情
ZNTL240517C10000
- 2.05
- -0.13-5.96%
延時15分鐘行情收盤價 05/17 16:00 (美東)
2.15最高價2.05最低價
2.15今開2.18昨收10張成交量11張未平倉合約數10.00行權價2075.00成交額2096.82%引伸波幅1.08%溢價2024/05/17到期日2.07内在价值100合約乘數-1天距到期日0.00時間價值100合約規模美式期權類型0.8814Delta0.0958Gamma5.49槓桿倍數-8.3523Theta0.0000Rho4.84有效槓桿0.0002Vega
分時
- 5日
- 日K
新聞
Zentalis Pharmicals將出席TD Cowen第五屆年度腫瘤學創新峯會
紐約和聖地亞哥，2024年5月14日（GLOBE NEWSWIRE）——Zentalis Pharmicals, Inc.（納斯達克股票代碼：ZNTL），一家處於臨床階段的生物製藥公司，正在發現和開發具有臨床差異化的小型生物製藥公司
評估Zentalis製藥：在財務穩定和不確定的市場前景中保持平衡的持有評級
分析師提供有關醫療保健公司的見解：梯瓦製藥（TEVA）、Zentalis Pharmicals（ZNTL）和Paragon 28（FNA）
在對Azeno藥物試驗寄予厚望的情況下，對Zentalis製藥進行了買入評級
Stifel Nicolaus 仍然是 Zentalis Pharmicals (ZNTL) 的獲得買入評級
HC Wainwright & Co. 維持 Zentalis Pharmicals 處於買入狀態。
HC Wainwright & Co. 維持 Zentalis Pharmicals 處於買入狀態。
評論
The satisfactory 2.7 years cash runway is overshadowed by increased cash burn rate of 19%. The firm's potential to raise funds for growth via new shares may entail dilution of existing ones. Close monitoring of Zentalis Pharmaceuticals' cash burn situation advised.
We're Hopeful That Zentalis Pharmaceuticals (NASDAQ:ZNTL) Will Use Its Cash Wisely
Gainers:
• $Enphase Energy(ENPH.US$ +8.2% (earnings reports)
• $Zentalis Pharmaceuticals(ZNTL.US$ +7.6% (announces $25 mln equity investment from Pfizer (PFE); enters into development collaboration for ZN-c3)
• $特爾尼翁鋼鐵(TX.US$ +6.1% (earnings reports)
• $PureCycle Technologies(PCT.US$ +5% (SEC concludes investigation without further action)
• $Alliance Resource(ARLP.US$ +4.7% (increases dividend; provides prelim qtrly results)
• $Digital World Acquisition Corp(DWAC.US$ +4.5% (cu...
• $Enphase Energy(ENPH.US$ +8.2% (earnings reports)
• $Zentalis Pharmaceuticals(ZNTL.US$ +7.6% (announces $25 mln equity investment from Pfizer (PFE); enters into development collaboration for ZN-c3)
• $特爾尼翁鋼鐵(TX.US$ +6.1% (earnings reports)
• $PureCycle Technologies(PCT.US$ +5% (SEC concludes investigation without further action)
• $Alliance Resource(ARLP.US$ +4.7% (increases dividend; provides prelim qtrly results)
• $Digital World Acquisition Corp(DWAC.US$ +4.5% (cu...
14
1
Upgrades
• $Banc of California(BANC.US$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $庫倫佛寺銀行(CFR.US$: Raymond James Upgrades to Outperform from Market Perform
• $美國固安捷(GWW.US$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US$: Raymond James Upgrades to Outperform from Market Perfor...
• $Banc of California(BANC.US$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $庫倫佛寺銀行(CFR.US$: Raymond James Upgrades to Outperform from Market Perform
• $美國固安捷(GWW.US$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes(INVH.US$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US$: Raymond James Upgrades to Outperform from Market Perfor...
7
閱讀更多